Open-house pharmaceutical discount agreements for Atovaquone

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Mar 03, 2028 · 553 days left·Open·Supplies·Framework

Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Atovaquon, ATC P01AX06

58/100

Opportunity Score

Needs reviewMedium complexity

SuppliesFrameworkOpen

Why this score?

Opportunity

58 / 100

Complexity

45 / 100

Risk factors

The notice uses an open procedure form, but both structured data and XML state the substance is an open-house model out...

Timing is strict: to start on the next month’s first day, complete documents must arrive by the 3rd of the month; for p...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Overview

Moderate opportunity

Key Facts

Framework procurement
Supplies contract
1 lot
Duration until Apr 2028
Non-exclusive pharmaceutical discount agreement for Atovaquone (ATC P01AX06).
Open-house accession model with identical, pre-defined contractual terms for all eligible companies.

Show full summary

This is an open-house supply arrangement for pharmaceutical discount agreements on Atovaquone (ATC P01AX06) by AOK Bayern. It is not a competitive award procedure in substance, but an accession model with identical non-negotiable terms for all eligible pharmaceutical companies. Contracting is possible until 03.03.2028, with possible start dates on the first day of the following month if complete documents are received by the 3rd, or the month after if later. No contract value is stated.

Risks

The notice uses an open procedure form, but both structured data and XML state the substance is an open-house model out...

Timing is strict: to start on the next month’s first day, complete documents must arrive by the 3rd of the month; for p...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

The contract and the annex 'Festlegung der vertragsgegenständlichen Arzneimittel' must be completed and signed.

Eligibility

Only pharmaceutical companies are eligible as potential contract partners.

Administrative

A signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit) must be submitted.

Buyer

Name

AOK Bayern - Die Gesundheitskasse

Location

München, DEU

[email protected]

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open-house pharmaceutical discount agreements for Atovaquone

Single lot covering non-exclusive open-house Rabattverträge for the active substance Atovaquone (ATC P01AX06). The lot is for supply-type pharmaceutical products in Germany (Bavaria/Munich contracting authority). Terms are fixed and non-individually negotiable.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Apr 2026 - Apr 2028

Procurement Details

Publication date: 15 Mar 2026
Languages: German

Reference metadata

Legal basis: 32014L0024

Reference IDs

Tender ID: 179704-2026

Documents (2)

Procurement document 1 Submission portal 1

Similar tenders

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3